← Eichor
Study identifier: NCT06094569 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Medical Imaging Screening for Posterior-circulation Ischemic Stroke

Condition: Endovascular Thrombectomy  ·  Sponsor: Tianjin Huanhu Hospital

PhaseN/A
Planned participants1000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Patients with ischemic stroke in the posterior circulation continue to have high rates of mortality and disability, even with aggressive treatment. We wanted to evaluate preoperative imaging to screen patients with a good prognosis from mechanical embolization. We assess the degree of ischemia by defining the pons-midbrain-medulla index (PMMI) and correlate the preoperative PMMI with the clinical prognosis of postoperative patients to verify the validity of PMMI in predicting the clinical prognosis of patients with embolization.

This description comes directly from the study's public registry record.

Talk to the study team

Ming Wei, PhD  ·  13502182903  ·  drweiming@163.com

Always discuss trial participation with your own doctor first.

Locations (4)

Tianjin Medical University General HospitalTianjin, Tianjin Municipality, ChinaRecruiting
The Sencond Hospital of Tianjin Medical UniversityTianjin, Tianjin Municipality, ChinaRecruiting
Tianjin Huanhu HospitalTianjin, Tianjin Municipality, ChinaRecruiting
Beijing University Binhai HospitalTianjin, Tianjin Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06094569